The effect of weight change on kidney cancer patients treated with targeted therapy

A recent retrospective study of 3311 patients with metastatic renal cell carcinoma (RCC) and on first- or second-line targeted therapy clinical trials showed that patients who experience weight loss during treatment have worse outcomes compared with patients with stable weight at 6 and 12 weeks of treatment. Weight loss at 6 weeks after the start […]

read more

Effect of weight loss during treatment with targeted therapy

This large retrospective study of 3311 patients with metastatic renal cell carcinoma (RCC) was designed to investigate the effect of weight change on overall survival in patients treated with targeted therapy. During 12 weeks after starting first- or second-line treatment with a targeted therapy, 28% of patients had lost weight and 58% had stable weight. […]

read more
Showing all 2 results
  TOP